A. Bassi, P. Campolmi*, M. Dindelli, N. Bruscino, R.Conti , G. Cannarozzo and N. Pimpinelli* Department of Surgery and Translational Medicine, section of Dermatology University of Florence Medical School, Florence, Italy; *Dermatology and Physical Therapy Unit, Florence Health District, Florence, Italy ABSTRACT Background: Rhinophyma is a benign, disfiguring disorder, commonly (more…)
Steven Nisticò,1 Piero Campolmi,2 Silvia Moretti,2 Ester Del Duca,3 Nicola Bruscino,2 Rossana Conti,2 Andrea Bassi,2 and Giovanni Cannarozzo3 1Department of Dermatology, University of Rome “Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy 2Department of Dermatology, University of Florence, Florence, Italy 3Laser in Dermatology Unit, University of Rome “Tor Vergata”, Rome, (more…)
Steven Paul Nistico,1,2 Andrea Chiricozzi,3 Federica Tamburi,4 and Giovanni Cannarozzo2 1Department of Health Sciences, University of Catanzaro, Italy 2University of Rome Tor Vergata, Rome, Italy 3University of Pisa, Pisa, Italy 4Unit of Dermatology, Catholic University of Rome, Rome, Italy Laser technology represents nowadays an important advance in dermatology. Physical, technological (more…)
F. Prignano, P. Campolmi, P. Bonan, F. Ricceri, G. Cannarozzo, M. Troiano & T. Lotti Department of Dermatological Sciences, Florence University, Florence, Italy ABSTRACT Minimally ablative fractional laser devices have gained acceptance as a preferred method for skin resurfacing. Notable improvements in facial rhytides, photodamage, acne scarring, and skin laxity (more…)
Giovanni Cannarozzo, MD,1 Mario Sannino, MD,1 Federica Tamburi, MD,2 Andrea Chiricozzi, MD,1 Rosita Saraceno MD,1 Cristiano Morini, MD,1 and Steven Nistico` , MD3 1Laser in Dermatology, University of Rome, Tor Vergata, Italy. 2Unit of Dermatology, Complesso Integrato Columbus, Catholic University, Rome, Italy. 3Department of Health Sciences, University ‘‘Magna Graecia,’’ Catanzaro, (more…)
Giovanni Cannarozzo, MD,1 Mario Sannino, MD,1 Federica Tamburi, MD,2 Cristiano Morini, MD,1 and Steven Paul Nistico’, MD3 1Master’s degree course ‘‘Laser in Dermatology,’’ University of Rome, Tor Vergata, Italy. 2Unit of Dermatology, Complesso Integrato Columbus, Catholic University, Rome, Italy. 3Department of Health Sciences, University ‘‘Magna Graecia,’’ Catanzaro, Italy. Abstract (more…)
Giovanni Cannarozzo, MD,1 Diletta Bonciani, MD,2 Mario Sannino, MD,1 Federica Tamburi, MD,Cristiano Morini, MD,1,2 Domenico Piccolo MD,4 and Steven Paul Nistico1,5 1‘‘Laser in Dermatology,’’ University of Rome, Tor Vergata, Italy. 2Department of Surgery and Translational Medicine, Section of Dermatology, University of Florence, Florence, Italy. 3Unit of Dermatology, Complesso Integrato Columbus, (more…)
Domenico Piccolo, MD,1 Dimitra Kostaki, MD,2 Ester Del Duca, MD,3 Giovanni Cannarozzo, MD,4 Mario Sannino, MD,4 and Steven Nistico’ , MD5 1Italian Association Outpatient Dermatologists, Pescara, Italy. 2Skin Center Dermo-Aesthetic Lasers Centres, Pescara, Italy. 3Division of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. 4Lasers in (more…)
Maurizio Filippini, MD,1 Ester Del Duca, MD,2 Francesca Negosanti, MD,3,4 Diletta Bonciani, MD,5 Luca Negosanti, MD,6 Mario Sannino, MD,4 Giovanni Cannarozzo, MD,4 and Steven Paul Nistico’, MD4,7 1Department of Obstetric and Gynecology, Hospital State of Republic of San Marino, San Marino, Republic of San Marino. 2Department of Dermatology, University of (more…)
F. Dragoni, S. Moretti, G. Cannarozzo & P. Campolmi Section of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy ABSTRACT Purpose: Surgical treatment remains the first-line therapy of pilonidal cyst but is associated with high levels of postoperative pain, adverse events and a recurrence rate of (more…)
G. CANNAROZZO 1, 2, 3, C. MORINI 1, 2, 3, M. SANNINO 2, 3, P. CAMPOLMI 4, S. P. NISTICÒ 1, 2, 3, 4, 5 1Department of Dermatology, Tor Vergata University of Rome, Rome, Italy 2Unit of Dermatologic Surgery and Cutaneous Oncology, ASL Napoli 3 Sud, Italy 3GILD-FTP (Gruppo Italiano (more…)
Vascular lesions of the face represent an aesthetic problem and are a symptom of different skin diseases . Currently, laser technology can be considered an effective treatment modality for superficial vascular lesions of the face using light sources with visible (500–800 nm) and near-infrared (800–1,300 nm) wavelengths.
Abstract Many therapeutic options have been suggested for the treatment of vitiligo including non-surgical and surgical modalities. Non-surgical modalities, considered the first line therapy, include topical, intra-lesional and systemic corticosteroids, topical and oral psoralen plus ultraviolet A (PUVA), topical khellin 3%-4%-5%, broadband and narrow-band UVB (311 nm UVB phototherapy), and (more…)
The number of tattooed people has become more prevalent in the last few years for the continuous development of new trends especially among young people.
First introduced in 1990s, intense pulsed light (IPL) was obtained by U.S. Food and Drug Administration (FDA) authorization in 1995 for the treatment of lower-limb telangiectasias […]
In this open study, we tested the safety efficacy profile of sequential ablative laser and Ingenol Mebutate gel (IngMeb)